These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21444333)

  • 1. What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial.
    Aghaizu A; Adams EJ; Turner K; Kerry S; Hay P; Simms I; Oakeshott P
    Sex Transm Infect; 2011 Jun; 87(4):312-7. PubMed ID: 21444333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
    Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
    Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.
    Oakeshott P; Kerry S; Aghaizu A; Atherton H; Hay S; Taylor-Robinson D; Simms I; Hay P
    BMJ; 2010 Apr; 340():c1642. PubMed ID: 20378636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.
    Tamarelle J; Thiébaut ACM; Sabin B; Bébéar C; Judlin P; Fauconnier A; Rahib D; Méaude-Roufai L; Ravel J; Morré SA; de Barbeyrac B; Delarocque-Astagneau E;
    Trials; 2017 Nov; 18(1):534. PubMed ID: 29132441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases?
    Shafer MA; Pantell RH; Schachter J
    Arch Pediatr Adolesc Med; 1999 Feb; 153(2):119-25. PubMed ID: 9988241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 7. Proportional payment for pelvic inflammatory disease: who should pay for chlamydial screening?
    Nettleman MD; Jones RB
    Sex Transm Dis; 1989; 16(1):36-40. PubMed ID: 2667154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.
    Gottlieb SL; Xu F; Brunham RC
    Sex Transm Dis; 2013 Feb; 40(2):97-102. PubMed ID: 23324973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.
    Howell MR; Quinn TC; Gaydos CA
    Ann Intern Med; 1998 Feb; 128(4):277-84. PubMed ID: 9471930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the population excess fraction of Chlamydia trachomatis infection on pelvic inflammatory disease at 12-months in the presence and absence of chlamydia testing and treatment: Systematic review and retrospective cohort analysis.
    Davies B; Turner KM; Leung S; Yu BN; Frølund M; Benfield T; Blanchard J; Westh H; ; Ward H
    PLoS One; 2017; 12(2):e0171551. PubMed ID: 28199392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost effectiveness of opportunistic chlamydia screening in England.
    Adams EJ; Turner KM; Edmunds WJ
    Sex Transm Infect; 2007 Jul; 83(4):267-74; discussion 274-5. PubMed ID: 17475686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
    van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study.
    Herzog SA; Heijne JC; Scott P; Althaus CL; Low N
    Epidemiology; 2013 Nov; 24(6):854-62. PubMed ID: 24076992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic evaluation of a school-based sexually transmitted disease screening program.
    Wang LY; Burstein GR; Cohen DA
    Sex Transm Dis; 2002 Dec; 29(12):737-45. PubMed ID: 12466713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and effectiveness of Chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners.
    Nevin RL; Shuping EE; Frick KD; Gaydos JC; Gaydos CA
    Sex Transm Dis; 2008 Aug; 35(8):705-13. PubMed ID: 18461015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR; Gaydos CA; Quinn TC
    Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy.
    Blackwell AL; Thomas PD; Wareham K; Emery SJ
    Lancet; 1993 Jul; 342(8865):206-10. PubMed ID: 8100930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting.
    Blake DR; Maldeis N; Barnes MR; Hardick A; Quinn TC; Gaydos CA
    Sex Transm Dis; 2008 Jul; 35(7):649-55. PubMed ID: 18461013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.
    Howell MR; Quinn TC; Brathwaite W; Gaydos CA
    Sex Transm Dis; 1998 Feb; 25(2):108-17. PubMed ID: 9518379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.